Drug Research and Drug Development in the 21st Century Science and Ethics /

Drug Research and Drug Development in the 21st Century Science and Ethics /

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Wolff, H.P. (Editor), Fleckenstein, A. (Editor), Philipp, Egon O. (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 1989.
Edition:1st ed. 1989.
Series:Bayer AG Centenary Symposium,
Subjects:
Pharmacology.
Cardiology.
Neurology .
Allergy.
Immunology.
Pharmacy.
Pharmacology/Toxicology.
Neurology.
Allergology.
Online Access:https://doi.org/10.1007/978-3-642-74615-4
Table of Contents:
  • History and Philosophy of Bayer Pharmaceutical Research
  • Science, Responsibility, and Society
  • Opening Remarks
  • Message of Greeting
  • I. Unresolved Problems of Chronic Diseases
  • Demographic and Epidemiologic Trends Today
  • Atherosclerosis and Coronary Heart Disease
  • Rheumatoid Arthritis: A Modell of Chronic Inflammation
  • Alzheimer's Disease
  • Obstructive Lung Disease
  • Biological Approaches to Cancer Therapy
  • Challenges and Obstacles hi Clinical Evaluations of Therapy
  • Problems, Pitfalls, and Opportunities in Long-term Randomized Trials
  • The Impact of Clinical Trials on Clinical Practice
  • Panel Discussion I: Cost Effectiveness of Drug Development and Health Economics
  • II. Advanced Technologies, Scientific Achievements
  • Receptors and Messengers
  • Low Density Lipoproteins and Hypercholesterolemia
  • Leukotrienes in Airways and Blood Vessels
  • Drug Design
  • Opening Remarks
  • Thoughts About Gene Regulation and Mammalian Development
  • Protein Crystallography and Drug Design
  • Applying Engineering Principles to the Design of Cellular Biology
  • Analytical Pathophysiology and Biochemistry
  • Opening Remarks
  • Neurotransmitters in the Brain
  • Mechanisms of Cancer Metastasis
  • Panel Discussion II: Objectives of Basic Research and Predictive Value Preclinical Testing
  • The Patient as a Subject to Medical Research
  • Ethics of Drug Research and Drug Development
  • The Functions of Ethical Committees
  • Reduction of Risk to Patients Through Optimized Planning of Clinical Drug Development
  • The Quality of Life of Hypertensive Patients in Long-term Studies
  • Panel Discussion III: Who is Concerned with Patient Welfare in Research?
  • Concluding Remarks.

Similar Items